SCHEMBL19123731

SCHEMBL19123731

COC(=O)c1c(-c2ccccc2C)nsc1-c1ccc(OC)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.50
TDP1 Q9NUW8 3/20 0.50
ATM Q13315 2/20 0.50
OPRD1 P41143 1/20 0.44
KDM4E B2RXH2 3/20 0.43
PKM P14618 1/20 0.43
MAPT P10636 3/20 0.42
ALDH1A1 P00352 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GRM5 P41594 2/20 0.41
GRM6 O15303 1/20 0.41
TP53 P04637 2/20 0.41
THRB P10828 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
GRM1 Q13255 2/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 1/20 0.40
NPC1 O15118 1/20 0.39
CNR1 P21554 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19123777 0.89 MAPT (0.43) L3MBTL1TDP1ATMMAPTALDH1A1
SCHEMBL17845090 0.87 L3MBTL1 (0.49) L3MBTL1TDP1ATMOPRD1KDM4E
SCHEMBL17736162 0.79 L3MBTL1 (0.52) L3MBTL1TDP1ATMOPRD1KDM4E
SCHEMBL17845084 0.76 GPBAR1 (0.44) L3MBTL1TDP1ATMMAPTALDH1A1
SCHEMBL16049254 0.76 L3MBTL1 (0.51) L3MBTL1TDP1ATMOPRD1KDM4E
SCHEMBL17736160 0.70 ALDH1A1 (0.46) KDM4EPKMMAPTALDH1A1GRM6
SCHEMBL17845139 0.69 CNR1 (0.43) L3MBTL1MAPTKMT2ALMNAGAA
SCHEMBL17736158 0.69 GRM6 (0.42) L3MBTL1TDP1ATMOPRD1KDM4E
SCHEMBL28692232 0.68 PPARD (0.40) TDP1OPRD1MAPTALDH1A1MEN1
SCHEMBL12724852 0.68 CA12 (0.50) MAPTALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9845291-B2 Estrogen receptor modulators and uses thereof GENENTECH, INC. (US) 2017-12-19 US disclosed
US-20170197915-A9 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF GENENTECH, INC. (US) 2017-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170197915-A9 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF ESR2, ESR1, GPER1 L3MBTL1 4873/4885TDP1 4001/4885ATM 2030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.